Home  >  News
News
  SEMCO aswarded SBIR phase 1 NCI contract to study its lead molecules in preclinical model of triple negative breast cancer,   January 16, 2018
  Dynasil submits Xcede Technologies' application for first-in-human trial,   January 15, 2018
  Glenmark receives DCGI nod to start phase IIb dose range study of GRC 27864 to treat osteoarthritic pain,   January 15, 2018
  MERS antibodies produced in cattle safe, treatment well tolerated in phase 1 trial,   January 15, 2018
  US FDA accepts Resverlogix's phase 3 BETonMACE trial protocol amendments,   January 15, 2018
  Immunovia signs collaboration with Denmark’s Diabetes Center for Strategic Research for pancreas cancer study of new onset diabetics,   January 13, 2018
  Study supports use of short-term HIV treatment interruption in clinical trials,   January 13, 2018
  Syndax Pharma inks clinical collaboration with Genentech to evaluate entinostat in combo with anti-PD-L1 cancer immunotherapy in breast cancer,   January 12, 2018
  RadioMedix, Areva Med begin phase 1 trial of AlphaMedix to treat neuroendocrine tumours,   January 12, 2018
  US FDA accepts InflaRx's IND, company to begin phase IIb trial with IFX-1 in Hidradenitis Suppurativa,   January 11, 2018
  BioProtect begins study of ProSpace biodegradable spacer to protect rectum, lower GI tract during radiation therapy,   January 11, 2018
  Inovio, Parker Institute for Cancer Immunotherapy enter clinical collaboration to evaluate new cancer immunotherapy combinations,   January 11, 2018
  Novartis advances head-to-head superiority trials of Cosentyx versus Humira and proposed biosimilar adalimumab,   January 10, 2018
  Merck's phase 3 EORTC1325/KEYNOTE-054 trial of Keytruda meets primary endpoint of recurrence-free survival,   January 09, 2018
  Medivir completes pre-clinical safety studies with MIV-818 to treat hepatocellular carcinoma,   January 08, 2018
  Akcea begins phase 2b study of AKCEA-APOCIII-LRx in patients with hypertriglyceridemia & established CVD,   January 08, 2018
  Avelas completes patient enrollment in phase 2 study of AVB-620 in women with primary, nonrecurrent breast cancer undergoing surgery,   January 08, 2018
  RDD Pharma completes enrollment in European phase 3 trial of RDD-1219 to treat chronic anal fissure,   January 06, 2018
  ReCor Medical completes patient enrollment in RADIANCE-HTN SOLO hypertension study,   January 06, 2018
  NIH funded study shows stem cell transplant for severe scleroderma improves survival, quality of life,   January 05, 2018

 Back
 
duphat_150x60
IPJPI18_150x60en_2018
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |